Skip Prep of Vaginal Delivery to Prevent Puerperal / Perinatal Infection in Vaginal Delivery
Launched by SEOUL NATIONAL UNIVERSITY HOSPITAL · Nov 8, 2021
Trial Information
Current as of July 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at the best way to prepare the skin before vaginal delivery to help prevent infections after childbirth. Specifically, researchers want to compare two different skin cleaning methods—using chlorhexidine-alcohol or povidone-iodine—to see which one is more effective at reducing infections at the site of an episiotomy, which is a small cut made during delivery to help with birth.
To participate in this study, women need to be pregnant with one baby and planning to have a vaginal delivery after 37 weeks of pregnancy. However, women who have allergies to chlorhexidine, alcohol, iodine, or shellfish, or who have any infections in the area before delivery, will not be eligible. If you decide to join the trial, you will be randomly assigned to one of the two cleaning methods before delivery. This research is important because it aims to improve the health and safety of mothers and babies during and after childbirth.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Women with singleton pregnancy
- • Women who will undergo vaginal delivery after 37+0/7 weeks of gestation
- Exclusion Criteria:
- • Women who are allergy to chlorhexidine, alcohol, iodine, or shellfish
- • Women with any infection at perineum (before vaginal delivery)
About Seoul National University Hospital
Seoul National University Hospital (SNUH) is a leading medical institution in South Korea, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent clinical trial sponsor, SNUH integrates cutting-edge scientific inquiry with patient-centered care, facilitating the development of novel therapies and treatment protocols. The hospital boasts a diverse range of specialized departments and a robust infrastructure for conducting clinical studies, ensuring rigorous adherence to ethical standards and regulatory compliance. By fostering collaboration among multidisciplinary teams, SNUH aims to contribute significantly to global medical advancements and improve patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials